MedTech News
New approach to pancreatic cancer treatment expands therapeutic possibilities, shows promise for increased survival
Preclinical research published in the Journal for ImmunoTherapy of Cancer points to a promising new treatment option for people with pancreatic cancer. Researchers from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) suggest that when used in a form that can be delivered directly into the tumor cell, polyinosine–polycytidylic acid (pIC) suppresses tumor growth, induces cancer cell death and enhances survival in animal models with the most common form of pancreatic cancer
Where and how you sit matters when getting blood pressure taken at the doctor’s office
Millions of people with normal blood pressure may be misclassified as having blood pressure that is too high because of improper positioning when measurements are taken, new research suggests.
FDA clears Owlet over-the-counter pulse oximeter sock for infants
Lehi, Utah-based Owlet designed the system to enable caregivers to better care for babies at home through advanced digital technologies.
Recor Medical wins first FDA nod for renal denervation to treat hypertension
Recor Medical announced that the FDA approved its Paradise ultrasound renal denervation (RDN) system for treating hypertension.
Abbott launches dual-chamber pacemaker with first U.S. implants
The first U.S. commercial cases have been completed with the Abbott (NYSE: ABT)+
Aveir dual-chamber leadless pacemaker technology.
Anesthesia technology precisely controls unconsciousness in animal tests
An advanced closed-loop anesthesia delivery system that monitors brain state to tailor propofol dose and achieve exactly the desired level of unconsciousness could reduce post-op side effects.
J&J’s Ethicon unveils AI-powered laparoscopic training tech
Johnson & Johnson MedTech’s (NYSE: JNJ)+
Ethicon unit today debuted an AI-powered laparoscopic surgical simulation platform.
J&J links radiofrequency catheter to improved quality of life in atrial fibrillation study
Scores on a quality-of-life scale improved and use of antiarrhythmic drugs fell after people underwent treatment with the device.